TrialJournal of the American Society of Nephrology : JASN2020

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.

An S De Vriese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.